The UK government's recent decision to move toward enabling human trials in which mitochondrial replacement from donor DNA would be used to treat mitochondrial disease in embryos has stirred up a predictable ethical debate. Does this step effectively green-light human germline modification, a step possibly towards even more profound human genetic engineering?

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Three-Person IVF

Facing the Past

Hope and Concern

New Technique a 'Go'

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.

In Science this week: gene linked to expansion of the human neocortex, and more.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.